Literature DB >> 24509734

Milestone approval lifts Illumina's NGS from research into clinic.

Cormac Sheridan.   

Abstract

Mesh：

Year:  2014        PMID： 24509734     DOI： 10.1038/nbt0214-111

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  4 in total

1.  First FDA authorization for next-generation sequencer.

Authors:  Francis S Collins; Margaret A Hamburg
Journal:  N Engl J Med       Date:  2013-11-19       Impact factor: 91.245

2.  Irresistible force meets immoveable object.

Authors: 
Journal:  Nat Biotechnol       Date:  2014-01       Impact factor: 54.908

3.  Assuring the quality of next-generation sequencing in clinical laboratory practice.

Authors:  Amy S Gargis; Lisa Kalman; Meredith W Berry; David P Bick; David P Dimmock; Tina Hambuch; Fei Lu; Elaine Lyon; Karl V Voelkerding; Barbara A Zehnbauer; Richa Agarwala; Sarah F Bennett; Bin Chen; Ephrem L H Chin; John G Compton; Soma Das; Daniel H Farkas; Matthew J Ferber; Birgit H Funke; Manohar R Furtado; Lilia M Ganova-Raeva; Ute Geigenmüller; Sandra J Gunselman; Madhuri R Hegde; Philip L F Johnson; Andrew Kasarskis; Shashikant Kulkarni; Thomas Lenk; C S Jonathan Liu; Megan Manion; Teri A Manolio; Elaine R Mardis; Jason D Merker; Mangalathu S Rajeevan; Martin G Reese; Heidi L Rehm; Birgitte B Simen; Joanne M Yeakley; Justin M Zook; Ira M Lubin
Journal:  Nat Biotechnol       Date:  2012-11       Impact factor: 54.908

4.  A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study.

Authors:  C A Drukker; J M Bueno-de-Mesquita; V P Retèl; W H van Harten; H van Tinteren; J Wesseling; R M H Roumen; M Knauer; L J van 't Veer; G S Sonke; E J T Rutgers; M J van de Vijver; S C Linn
Journal:  Int J Cancer       Date:  2013-03-04       Impact factor: 7.396
  4 in total
  15 in total

Review 1.  Reference standards for next-generation sequencing.

Authors:  Simon A Hardwick; Ira W Deveson; Tim R Mercer
Journal:  Nat Rev Genet       Date:  2017-06-19       Impact factor: 53.242

Review 2.  The Role of BEAMing and Digital PCR for Multiplexed Analysis in Molecular Oncology in the Era of Next-Generation Sequencing.

Authors:  Jérôme Alexandre Denis; Erell Guillerm; Florence Coulet; Annette K Larsen; Jean-Marc Lacorte
Journal:  Mol Diagn Ther       Date:  2017-12       Impact factor: 4.074

3.  FDA wades into sequencing-based diagnostics regulation.

Authors:  Justin Petrone
Journal:  Nat Biotechnol       Date:  2016-07-12       Impact factor: 54.908

Review 4.  Progress towards the integration of pharmacogenomics in practice.

Authors:  Sean D Mooney
Journal:  Hum Genet       Date:  2014-09-11       Impact factor: 4.132

Review 5.  Emerging technologies for monitoring drug-resistant tuberculosis at the point-of-care.

Authors:  Vigneshwaran Mani; ShuQi Wang; Fatih Inci; Gennaro De Libero; Amit Singhal; Utkan Demirci
Journal:  Adv Drug Deliv Rev       Date:  2014-06-02       Impact factor: 15.470

6.  Evaluating the Stability of RNA-Seq Transcriptome Profiles and Drug-Induced Immune-Related Expression Changes in Whole Blood.

Authors:  John F Bowyer; Karen M Tranter; Joseph P Hanig; Nathaniel M Crabtree; Robert P Schleimer; Nysia I George
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

7.  Whole genome sequencing in pharmacogenomics.

Authors:  Theodora Katsila; George P Patrinos
Journal:  Front Pharmacol       Date:  2015-03-26       Impact factor: 5.810

Review 8.  Next-generation sequencing in clinical oncology: next steps towards clinical validation.

Authors:  Nigel C Bennett; Camile S Farah
Journal:  Cancers (Basel)       Date:  2014-11-18       Impact factor: 6.639

9.  Chromosome-scale shotgun assembly using an in vitro method for long-range linkage.

Authors:  Nicholas H Putnam; Brendan L O'Connell; Jonathan C Stites; Brandon J Rice; Marco Blanchette; Robert Calef; Christopher J Troll; Andrew Fields; Paul D Hartley; Charles W Sugnet; David Haussler; Daniel S Rokhsar; Richard E Green
Journal:  Genome Res       Date:  2016-02-04       Impact factor: 9.043

Review 10.  The application of transcriptional blood signatures to enhance our understanding of the host response to infection: the example of tuberculosis.

Authors:  Simon Blankley; Matthew Paul Reddoch Berry; Christine M Graham; Chloe I Bloom; Marc Lipman; Anne O'Garra
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-05-12       Impact factor: 6.237
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.